Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Revenue | 13.77B | 4.97B |
| Cost of revenue | 5.92B | 1.35B |
| Research and development | 344M | 635M |
| Selling, general and administrative | 433M | 312M |
| Operating expenses | 8.61B | 3.21B |
| Operating income | 5.16B | 1.76B |
| Pre-tax income | 3.36B | 2.18B |
| Income tax | 630M | 437M |
| Net income | 2.26B | 1.48B |
| Earnings per share | 0.93 | 0.63 |
| Earnings per share, diluted | 0.86 | 0.57 |
| Weighted average shares | 2.43B | 2.35B |
| Weighted average shares, diluted | 2.64B | 2.59B |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.60B | 2.36B | 1.88B | 2.25B | 3.61B | 3.61B | 5.64B | 4.46B |
| Receivables | 810M | 918M | 633M |
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Operating cash flow | 6.57B | 2.15B |
| Depreciation and amortisation | 941M | 322M |
| Share-based compensation | 46M | 22M |
| Capital expenditure | 13.37B | 13.72B |
| Investing cash flow | −13.22B | −14.16B |
| Dividends paid | 465M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 673M |
| 640M |
| 364M |
| — |
| — |
| Inventory | 241M | 253M | 227M | 184M | 189M | 171M | — | — |
| Current assets | 3.22B | 4.04B | 3.26B | 3.98B | 4.89B | 4.56B | — | — |
| Total assets | 56.30B | 53.45B | 50.08B | 46.51B | 45.05B | 43.49B | — | — |
| Current liabilities | 3.71B | 4.34B | 3.92B | 2.86B | 2.82B | 3.54B | — | — |
| Short-term debt | 126M | 812M | 856M | 197M | 193M | 190M | — | — |
| Long-term debt | 36.46B | 33.39B | 31.74B | 29.77B | 29.13B | 29.09B | — | — |
| Total liabilities | 43.96B | 41.45B | 39.26B | 36.10B | 35.13B | 35.60B | — | — |
| Equity | 7.23B | 6.74B | 5.69B | 5.27B | 4.88B | 2.90B | — | — |
| 139M |
| Financing cash flow | 5.47B | 10.75B |